HomeFilePeripheral vascular disease

Peripheral vascular disease

ESC 2025 | SWEDEPAD 1 and 2: Paclitaxel-Coated Devices in Peripheral Artery Disease

In patients with peripheral artery disease, “improving” prognosis means relieving walking pain, increasing walking distance, preventing amputations,...

Evolution of Renal Denervation at 24 Months

Arterial hypertension is a modifiable risk factor for cardiovascular events. In many cases, however, patients struggle to...

Statins and Small Abdominal Aortic Aneurysms: Unexpected Aid?

Courtesy of Dr. Juan Manuel Pérez. Abdominal aortic aneurysms (AAA) entail high morbimortality in case of rupture, and...

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

High blood pressure (BP) continues to be one of the leading preventable causes of cardiovascular events worldwide....

Post-Rotational Atherectomy Imaging in Femoropopliteal Lesions (INSIGHT-JETSTREAM)

Severely calcified femoropopliteal disease represents a significant clinical challenge, particularly concerning adequate lesion preparation before the implantation...

Renal Denervation, 24-Month Evolution

Hypertension is a very common condition, and generally manageable. However, as we know, it is associated to...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to...